Side effects of Wegovy 0.5mg: deciding whether they're manageable

What the 0.5mg step actually does to your body

Wegovy works by activating GLP-1 receptors involved in appetite regulation and gastric emptying, your stomach empties more slowly, and signals of fullness reach the brain sooner. The NHS medicines page for semaglutide explains that these same mechanisms are responsible for the majority of side effects, because a slower gut affects digestion across the board.

When you move from 0.25mg to 0.5mg, you're doubling the dose. That shift is deliberate, the 0.25mg starting level is purely about tolerability, and 0.5mg is where the medicine begins to do more meaningful work. The increase is also where most people notice side effects most sharply. That's not a sign something has gone wrong; it's the expected pattern.

The most common effects at this stage are nausea, diarrhoea, constipation, burping, and indigestion. Fatigue and mild headaches are also reported. For the majority of people, these effects are mild to moderate and fade within a week or two. Eating smaller portions, avoiding very fatty meals, and staying well hydrated all help. Our guide to the Wegovy dose schedule covers how titration is structured and why each step exists.

Less common at 0.5mg but worth knowing: some people experience dizziness or injection-site reactions (redness, itching, or a small lump where the pen was used). Rotating sites (abdomen, thigh, upper arm) reduces the latter.

The decision point: push through or pause?

This is the question most people at 0.5mg are actually asking. The honest answer is that mild-to-moderate nausea or loose stools in the first fortnight are not, on their own, a reason to stop. They're uncomfortable, not dangerous, and they usually pass.

The clearer reasons to contact your prescriber before your next dose are: side effects that are getting worse rather than better after two weeks; any GI symptoms severe enough to stop you eating or drinking normally for more than a day or two; or vomiting that's frequent and persistent. Dehydration from prolonged diarrhoea or vomiting can strain the kidneys, so it matters more than it might seem.

If you're tracking how your body responded to the earlier dose, our page on the side effects of Wegovy 0.25 is often where people first notice a real shift in how the medicine affects them. Knowing that pattern in advance makes it easier to interpret what you're feeling now.

Wegovy is a prescription-only medicine and every repeat at nume involves a clinical review, so if you have concerns before your next order, that's the right moment to raise them. A prescriber can advise on whether staying at 0.5mg a little longer makes sense before any further titration.

When to get medical help, and what counts as urgent

Most side effects at this dose are self-limiting. A few are not, and they need prompt attention.

Pancreatitis is a known but infrequent side effect of GLP-1 medicines. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis across this class. The symptom to act on is severe, persistent abdominal pain, particularly if it radiates through to your back, with or without vomiting. If that describes what you're feeling, stop the injection and get same-day medical advice; don't wait to see if it passes.

Other symptoms that warrant prompt attention: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, a widespread rash); sudden or significant changes in vision; and symptoms of gallbladder problems, which can include pain in the upper right abdomen, especially after eating.

Low mood or thoughts of self-harm should also be reported to a healthcare professional without delay. Our page on the side effects of Wegovy 0.5 covers how these signals present at this stage of treatment, and if you want to understand what to expect as you move from the 0.25mg to the 0.5mg dose, that page walks through the transition in detail, while our side-effect profile at higher Wegovy doses covers how they change as treatment progresses, but the urgent ones are consistent across all doses.

For a comprehensive, regularly updated overview of semaglutide side effects, the Wegovy SmPC on the electronic Medicines Compendium (eMC) is the authoritative clinical reference. Yellow Card reporting is open to patients as well as clinicians, you don't need a GP to submit a report, and every report helps the MHRA's ongoing safety monitoring.

Getting the right clinical support during titration

Side-effect management during dose titration isn't something you should be navigating on your own. At nume, a GPhC-registered prescriber reads every consultation (a real clinician, not an automated screen) and that applies to repeat orders too, not just the first one. If side effects are a factor in your decision about whether to continue, that conversation belongs in the consultation.

Our clinical team takes a straightforward view: suitability and side effects are discussed together, because one shapes the other. You can read more about the treatment landscape, including how Wegovy fits alongside other licensed options, on our weight-loss treatment overview. If you have general questions before starting, our FAQs cover the most common ones, including what to expect when you move on to 1.0 mg Wegovy and how that next step is managed, or you can get in touch with our support team directly.

If you're ready to discuss whether Wegovy is appropriate for you (including how the titration schedule works and what to expect at each step) start your free consultation and a prescriber will review your answers the same day.